Lexicon ([[LXRX]] -10.8% to $2.23) sinks sharply after pricing an offering of 17.5M shares at $2.25 each, a 10% discount to yesterday's close. The net proceeds will be $37.2M, which the biotech plans ...
Lexicon ( LXRX -10.8% to $2.23) sinks sharply after pricing an offering of 17.5M shares at $2.25 each, a 10% discount to yesterday's close. The net proceeds will be $37.2M, which the biotech plans to use for R&D. The underwriters have an option to purchase another 2.625M shares. ( PR ) Post your ...
Read the rest of this article on SeekingAlpha.com: SA Currents
Related Videos
-
No Sign of Slowdown in Biotech M&AHigh levels of merger and acquisition activity will be the big theme of year for biotech , says Morningstar's Lauren Migliore.
-
Top Biotech Acquisition Candidates2011 was a relatively light year for biotech M&A, but it looks like activity is picking up in 2012.
-
Our Top Five Biotech Takeout PicksHealth-care analyst Lauren Migliore looks at what makes a biotech firm a likely takeout candidate and reveals our top five biotech M&A picks for 2010.
-
Our Top Five Biotech Acquisition CandidatesM&A activity grew in 2010, and we expect deal volume to remain strong in 2011.